Isis Pharmaceuticals other research news

ISIP published two articles describing ways in which antisense drugs can be crafted to better target and inhibit the production of disease-causing proteins.

As reported in Biochemical Journal, the effect of various antisense molecule designs was tested on the bacterial version of the enzyme ribonuclease H to determine which antisense drugs can be more effective in interrupting the translation process and inhibiting the production of cancer-causing proteins. ...